Page 115 - Demo

Stock or patient-specific TMJ replacement1134Table 4: Primary and secondary outcome variables for custom(ized) TMJ TJR.Author, year Follow-up MMO mm (SD) Pain (VAS 0-10) Diet (VAS 0-10)Pre Post Pre Post Pre PostMercuri(13) (1995)Pre1 y2 y3 y24.2 (± 10.6)30.7 (± 8.2)31.6 (± 9.1)32.4 (± 8.7)8.44 (± 2.32)3.58 (±2.94)4.3 (± 3.2)4.18 (± 3.22)3.3 (± 2.3)7.3 (± 2.55)6.45 (± 2.6)Mercuri(11) (2002)Pre1 y2 y3 y25.5 (± 11.4)33.0 (± 6.6)31.6 (± 9.2)35 (± 8.7)7.4 (± 1.98)2.84 (± 2.29)3.03 (± 2.8)2.89 (± 2.32)3.55 (± 2.7)7.2 (± 2.07)7.3 (± 2.29)Mercuri(12)(2007)Pre1 y2 y3 y24.9 (± 10.5)31.6 (± 7.8)32.9 (± 7.1)33.6 (± 6.5)7.25 (± 2.6)3.11 (± 2.56)3.34 (± 2.8)3.41 (± 2.96)3.8 (± 2.71)7.11 (± 2.25)6.79 (± 2.71)Mercuri(23)(2008)Pre1 y2 y3 y14.0 (± 9.2)33.8 (± 7.9)27.4 (± 6.8)29.0 (± 7.9)6.69 (± 3.18)3.18 (± 3.2)3.75 (± 3.95)3.82 (± 3.44)2.42 (± 2.25)7.87 (± 2.84)8.36 (± 1.71)Kanatas(24)(2011)Pre1 y19.7 (± 10.8)28.2 (± 7.3)7.4 (± 3.1)1.6 (± 2.4)/ /Machon(25)(2012)Pre2 y27.5 (± 6.24)37.8 (± 11.62)1.7 (± 2.5)0.5 (± 1)/ /Sidebottom(15)(2013)Pre1 y22.4 (± 9.7)33.7 (± 6.2)7.2 (± 2.5) 0.8 (± 1.7) 3.8 (± 2.3) 9.3 (± 1.6)Aagaard(22)(2014)Pre1 y2 y3 y29.5 (± 11.3)38.7 (± 7.0)35.8 (± 5.6)31.8 (± 11.1)7.2 (± 2.6)1.8 (± 2.7)1.3 (± 1.5)1.6 (± 3.1)/ /Gruber(14)(2015)Pre1 y3 y21.0 (± 10)34 (± 6)35.5 (± 7)7.4 (± 2)0.9 (± 1)0.6 (± 2)4.1 (± 2)9.1 (± 2)9.7 (± 1)Nikolas de Meurechy NW.indd 113 05-06-2024 10:14